Exousia Bio, Inc.’s Q4 2026 10-K window runs Aug 24, 2026 to Oct 23, 2026.
Based on 3 prior 10-K filings.
Exousia Bio, Inc. · CIK 1939937 · Engraved from SEC EDGAR